Jeffrey Kraws

Jeffrey Kraws

Chairman at AVIVAGEN INC.

Net worth: 328 224 $ as of 2023-12-30

59 year
Finance
Health Technology
Consumer Services

Profile

Jeffrey J.
Kraws
is the founder of Crystal Research Associates (founded in 2003) where he holds the title of Chief Executive Officer.
He is also the founder of TopHat Capital LLC (founded in 2012) where he holds the title of Partner.
Additionally, he is the founder of Cra Advisors LLC (founded in 2003) where he holds the title of Chief Executive Officer.
Mr. Kraws's current job(s) include being the Independent Chairman at Avivagen, Inc. (since 2013), the Independent Non-Executive Chairman at Theriva Biologics, Inc. (since 2006), a Partner at Phoenix Holdings Ltd.
(US) (since 2015), a Partner at Grannus Securities Pty Ltd.
(since 2015), and a Partner at US Medical Innovations LLC.
Mr. Kraws's former job(s) include being a Managing Director-Healthcare Research at Ryan, Beck & Co., Inc., a Director at Saleen Automotive, Inc. (from 2013 to 2020), a Managing Director & Research Director at Gruntal & Co. LLC, a Director at Innovation1 Biotech, Inc. (from 2021 to 2023), a Senior Analyst at The Buckingham Research Group, Inc., an MD-Healthcare Research Group at First Union Securities, the President of IRG Research Group, the Co-President of The Investor Relations Group, Inc., the President of Ra Medical Systems, Inc. (from 2016 to 2021), and the President-Brokerage & Investment Banking Operation at Abb Aros Securities, Inc.Mr. Kraws's education history includes an MBA degree from Cornell University (conferred in 1988) and an undergraduate degree from State University of New York at Buffalo (conferred in 1986).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-01-11 1,389,055 ( 6.79% ) 327 817 $ 2023-12-30
2024-03-24 654 ( 0.00% ) 307 $ 2024-03-30
2023-03-02 50,000 ( 0.06% ) 100 $ 2024-03-30

Jeffrey Kraws active positions

CompaniesPositionStart
THERIVA BIOLOGICS, INC. Chairman 2012-05-13
AVIVAGEN INC. Chairman 2019-05-13
Founder 2002-12-31
Grannus Securities Pty Ltd. Corporate Officer/Principal 2015-10-31
Chief Executive Officer 2002-12-31
Corporate Officer/Principal 2015-10-31
Founder 2012-01-31
Corporate Officer/Principal -
All active positions of Jeffrey Kraws

Former positions of Jeffrey Kraws

CompaniesPositionEnd
INNOVATION1 BIOTECH INC. Chief Executive Officer 2022-12-05
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ -
See the detail of Jeffrey Kraws's experience

Training of Jeffrey Kraws

Cornell University Masters Business Admin
State University of New York at Buffalo Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jeffrey Kraws's experience

Connections

100 +

1st degree connections

20

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
AVIVAGEN INC.

Health Technology

THERIVA BIOLOGICS, INC.

Health Technology

Private companies16

Finance

Retail Trade

Finance

First Union Securities

Finance

IRG Research Group

Finance

Gruntal & Co. LLC

Government

Finance

Commercial Services

Health Technology

Finance

Grannus Securities Pty Ltd.

Finance

Innovation1 Biotech, Inc.

Abb Aros Securities, Inc.

Health Technology

Finance

See company connections